Therapeutic options in mantle cell lymphoma
- PMID: 18297516
- DOI: 10.1080/10428190701851364
Therapeutic options in mantle cell lymphoma
Abstract
Mantle cell lymphoma (MCL) is an aggressive lymphoma requiring intensive chemotherapy +/- autologous stem cell transplantation (SCT) to achieve optimal rates of progression-free survival. Here we review the treatment options for patients with newly-diagnosed or relapsed MCL and discuss recent advances in management, including the role of autologous and allogeneic SCT.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources